According to the report “Nucleic Acid Labelling Market By Product (Reagents & Kits, Services), By Labelling Technique (PCR, Nick Translation, Random Primer, In-Vitro Transcription, Reverse Transcription), By Application (DNA Sequencing, PCR, FISH, Microarrays, Blotting, In-Situ Hybridization), By End Users (Diagnostic Centres, Research Centres, Hospitals) And By Region – Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)” published by Market Data Forecast, the Global Nucleic Acid Labelling Market was worth $1381.81 million in 2016 and estimated to be growing at a CAGR of 8.65%, to reach $2090.27 million by 2021. Nucleic Acid Labelling has many applications in fields of drug discovery and identification of new diseases.
Nucleic acids are large complex molecules which carry genetic information. Two major types of nucleic acids are DNA and RNA. DNA carries forward function of hereditary characteristics to next generation while RNA carries protein synthesis. Nucleic acids are labelled with tags which facilitate the detection and purification process. There are many methods involving chemicals and enzymes for labelling nucleic acids like the corporation of fluorescent tags, radioactive phosphates, and modifications with biotin, which are primarily utilized in biotechnology applications.
The growth of Nucleic Acid Labelling market is attributed to factors like increasing expenditure for health care, increasing funding for R&D in genomics and disease diagnosis, increasing demand for personalized healthcare. However, factors like expensive processing techniques and lack of skilled professionals are likely to obstruct the growth of the market.
The Global Nucleic Acid Labelling market is segmented based on Product, Labelling Technique, Application and End-User. Based on Product – Reagents and Kits, Services. Based on Labelling Technique – PCR, Nick Translation, Random Primer, In-Vitro Transcription, Reverse Transcription. Based on Application – DNA Sequencing, PCR, Fluorescence in Situ Hybridization (FISH), Microarrays, Blotting, In-Situ Hybridization. Based on End-Users – Diagnostic Centres, Research Centres, Hospitals.
Based on the Geographical analysis the market is separated into regions of North America, Asia-Pacific, Europe, Latin America and Middle East and Africa. North America is leading the market while Europe is at second place. Increasing personalized medicines, identifying the genetic modifications and therapeutic areas have enabled North America to dominate the market. Asia Pacific is expected to grow the fastest due to government initiatives to develop healthcare infrastructure and making the products cost efficient and increased R&D expenditure. DNA sequencing occupies major share in terms of Applications due to its uses in identification of genetic disorders, tumour genetic variations. Reagents and Kits occupies a major share among products segment due to their numerous uses in Diagnostic and Research Centres. Based on End User Research Centres occupy the major share owing to increasing government funding to increase research activity and drug discovery.
Some of the key players dominating this market:
- Thermo Fisher Scientific
- New England Biolabs
- Hoffmann La-Roche AG
- General Electric Company
- Merck KGaA
- Enzo Biochem
- Promega Corporation
- Vector Laboratories
- Agilent Technologies
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
International Business Development Manager
Market Data Forecast
Direct Line: +1-888-702-9626; Mobile: +91 998 555 0206